Clinical Trial Update: A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) [Phase 3]

View source ↗

Summary

Phase 3 study comparing fidaxomicin (OPT-80) to vancomycin for safety and efficacy in Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fidaxomicin (fidaxomicin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Clostridium Difficile | Phase 3 | Status: COMPLETED